Skip to main content

Table 1 Adverse maternal and pregnancy outcomes before and after treatment policy change

From: Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

Adverse outcomes

Women with history of malaria during pregnancy

Women without history of malaria during pregnancy

Relative risks (95% CI)

P value

Population attributable risks % (95% CI)

March 2004–March 2006: before treatment policy change

 Maternal malaria: delivery, n/valid cases (%)

142/246 (57.7)

199/1,592 (12.5)

4.6 (3.9–5.5)

<0.001

34.5 (29.3–39.8)

  Primigravidae

56/91 (61.5)

70/490 (14.3)

4.3 (3.3–5.6)

<0.001

30.5 (22.1–38.9)

  Multigravidae

86/155 (55.5)

129/1,099 (11.7)

4.7 (3.8–5.8)

<0.001

33.1 (26.8–39.3)

 Maternal severe anaemia, n/valid cases (%)

40/241 (16.6)

152/1,588 (9.6)

1.7 (1.3–2.4)

<0.001

8.8 (4.4–13.4)

 Low birth weight, n/valid cases (%)

50/244 (20)

215/1,608 (13.4)

1.5 (1.2–2.0)

0.003

6.6 (3.2–10.0)

 Preterm delivery, n/valid cases (%)

27/225 (12)

110/1,503 (7.3)

1.6 (1.1–2.4)

0.015

7.8 (2.7–12.9)

 Perinatal deaths, n/valid cases (%)

11/248 (4.4)

41/1,619 (2.5)

1.75 (0.9–3.2)

0.1

9.1 (0.1–18)

 Congenital malaria, n/valid cases (%)

14/195 (7.1)

14/706 (1.9)

3.8 (1.8–8.2)

<0.001

25.7 (3.5–48)

April 2006–May 2010: After treatment policy change

 Maternal malaria: delivery, n/valid cases (%)

201/770 (26.1)

508/3,632 (13.9)

1.9 (1.6–2.2)

<0.001

13 (10.3–15.9)

  Primigravidae

81/265 (30.6)

185/1,112 (16.6)

1.8 (1.5–2.3)

<0.001

12.7 (7.9–17.5)

  Multigravidae

120/505 (23.8)

324/2,515 (12.9)

1.8 (1.5–2.2)

<0.001

12.8 (9.3–16.3)

 Maternal severe anaemia, n/valid cases (%)

70/738 (9.5)

237/3,510 (6.8)

1.4 (1.1–1.8)

0.01

6.6 (3.2–10.1)

 Low birth weight, n/valid cases (%)

123/764 (16.1)

521/3,615 (14.4)

1.1 (0.9–1.3)

0.23

2 (0.1–3.9)

 Preterm delivery, n/valid cases (%)

121/740 (16.4)

462/3,472 (13.3)

1.2 (1.0–1.5)

0.03

3.8 (1.8–5.8)

 Perinatal deaths, n/valid cases (%)

27/770 (3.5)

165/3,632 (4.5)

0.8 (0.5–1.2)

0.21

n/a

 Congenital malaria, n/valid cases (%)

1/743 (0.1)

6/3,543 (0.2)

0.8 (0.1–6.6)

0.21

n/a

  1. Valid cases refer to presence of variables required for the analysis.